Paper26316017
Risk of wound infection and safety profile of amoxicillin in healthy patients which required third molar surgery: a systematic review and meta-analysis.
Isiordia-Espinoza MA and 3 others. Br J Oral Maxillofac Surg, 2015. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Risk of wound infection and safety profile of amoxicillin in healthy patients which required third molar surgery: a systematic review and meta-analysis. Papers, record 26316017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26316017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk of wound infection and safety profile of amoxicillin in healthy patients which required third molar surgery: a systematic review and meta-analysis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amoxicillin | Major topic |
| Anti-Bacterial Agents | Major topic |
| Surgical Wound Infection | Major topic |
| Humans | |
| Molar, Third | |
| Risk | |
| Safety |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03130933 | Complications After Lower Third Molar Surgery | Results |
Source ClinicalTrials.gov
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41463712 | Influence of Amoxicillin Dosage and Time of Administration on Postoperative Complications After Impacted Third Molar Surgery: A Randomized, Double-Blind, Controlled Clinical Trial. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41463712 | PubMed |
| 41286855 | Rational utilization of antibiotic prophylaxis in oral and maxillofacial surgery: a large scope review of recent data. | BMC Oral Health | 2025 | https://conductscience.org/library/papers/41286855 | PubMed |
| 40454567 | Pharmacokinetics of Amoxicillin in the Cat. | J Vet Pharmacol Ther | 2025 | https://conductscience.org/library/papers/40454567 | PubMed |
| 40443423 | Severe Infections after Tooth Removal: a Retrospective Cohort Study. | J Oral Maxillofac Res | 2025 | https://conductscience.org/library/papers/40443423 | PubMed |
| 40136735 | Antibiotic Prescription for the Prevention of Postoperative Complications After Third-Molar Extractions: A Systematic Review. | Dent J (Basel) | 2025 | https://conductscience.org/library/papers/40136735 | PubMed |
| 38766279 | Close follow-up instead of antibiotic therapy after mandibular third molar surgery: A clinical trial. | Saudi Dent J | 2024 | https://conductscience.org/library/papers/38766279 | PubMed |
| 36009894 | Status of Microbiota in Odontogenic Inflammatory Lesions and Dental Surgery Procedures Performed on an Outpatient Basis. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36009894 | PubMed |
| 33919715 | A Meta-Analysis of the Analgesic Efficacy of Single-Doses of Ibuprofen Compared to Traditional Non-Opioid Analgesics Following Third Molar Surgery. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33919715 | PubMed |
| 33624847 | Antibiotics to prevent complications following tooth extractions. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/33624847 | PubMed |
| 32884898 | Critical analysis of methodological quality of systematic reviews and meta-analysis of antibiotics in third molar surgeries using AMSTAR 2. | J Oral Biol Craniofac Res | 2020 | https://conductscience.org/library/papers/32884898 | PubMed |
| 31687380 | Evaluation of Drug Susceptibility of Microorganisms in Odontogenic Inflammations and Dental Surgery Procedures Performed on an Outpatient Basis. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31687380 | PubMed |
| 30945142 | A systematic review of latest evidence for antibiotic prophylaxis and therapy in oral and maxillofacial surgery. | Infection | 2019 | https://conductscience.org/library/papers/30945142 | PubMed |
| 29618877 | Infection, Alveolar Osteitis, and Adverse Effects Using Metronidazole in Healthy Patients Undergoing Third Molar Surgery: A Meta-analysis. | J Maxillofac Oral Surg | 2018 | https://conductscience.org/library/papers/29618877 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| AMOXICILLIN | CHEMBL1082 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1082 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26316017
GET https://conductscience.org/api/papers/v1/26316017/authors